Hypovitaminosis D and reduced cathelicidin are strongly correlated during the multidrug therapy against leprosy-Reference-Cited by-同舟云学术

Hypovitaminosis D and reduced cathelicidin are strongly correlated during the multidrug therapy against leprosy

Published:2020-10 Issue: Volume:147 Page:104373
ISSN:0882-4010
Container-title:Microbial Pathogenesis
language:en
Short-container-title:Microbial Pathogenesis

Author:

Grossi de Oliveira Ana Laura^ORCID,Chaves Ana Thereza,Santos Cardoso Mariana^ORCID,Gomide Pinheiro Guilherme Rafael^ORCID,Parreiras de Jesus Augusto César,de Faria Grossi Maria Aparecida,Lyon Sandra,Lacerda Bueno Lilian,da Costa Rocha Manoel Otávio^ORCID,Toshio Fujiwara Ricardo^ORCID,Alves da Silva Menezes Cristiane

Funder

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology

Reference44 articles.

1. Weekly Epidemiological Record. Global Leprosy Update, 2018: Moving towards a Leprosy-free World;WHO,2019

2. Diet-related risk factors for leprosy: a case-control study;Wagenaar;PLoS Neglected Trop. Dis.,2015

3. Dietary diversity and poverty as risk factors for leprosy in Indonesia: a case-control study;Oktaria;PLoS Neglected Trop. Dis.,2018

4. Vitamin D and human health: more than just bone;White;Nat. Rev. Endocrinol.,2013

5. Micronutrients influencing the immune response in leprosy;Passos-Vázquez;Nutr. Hosp.,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infection, Autoimmunity, and Vitamin D;Infection and Autoimmunity;2024

2. Perspective Chapter: Interferon-Gamma in Natural Defence and Prevention of Leprosy;Basic and Clinical Aspects of Interferon Gamma;2022-10-05

3. Reduced vitamin D receptor (VDR) and cathelicidin antimicrobial peptide (CAMP) gene expression contribute to the maintenance of inflammatory immune response in leprosy patients;Microbes and Infection;2022-09

4. A review of nutrition in neuropathic pain of leprosy;Therapeutic Advances in Infectious Disease;2022-01